1. Home
  2. RCEL vs STHO Comparison

RCEL vs STHO Comparison

Compare RCEL & STHO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCEL
  • STHO
  • Stock Information
  • Founded
  • RCEL N/A
  • STHO N/A
  • Country
  • RCEL United States
  • STHO United States
  • Employees
  • RCEL N/A
  • STHO N/A
  • Industry
  • RCEL Medical/Dental Instruments
  • STHO Real Estate
  • Sector
  • RCEL Health Care
  • STHO Real Estate
  • Exchange
  • RCEL Nasdaq
  • STHO Nasdaq
  • Market Cap
  • RCEL 140.5M
  • STHO 112.7M
  • IPO Year
  • RCEL N/A
  • STHO N/A
  • Fundamental
  • Price
  • RCEL $5.33
  • STHO $7.62
  • Analyst Decision
  • RCEL Strong Buy
  • STHO
  • Analyst Count
  • RCEL 4
  • STHO 0
  • Target Price
  • RCEL $13.75
  • STHO N/A
  • AVG Volume (30 Days)
  • RCEL 267.6K
  • STHO 45.9K
  • Earning Date
  • RCEL 11-06-2025
  • STHO 11-04-2025
  • Dividend Yield
  • RCEL N/A
  • STHO N/A
  • EPS Growth
  • RCEL N/A
  • STHO N/A
  • EPS
  • RCEL N/A
  • STHO N/A
  • Revenue
  • RCEL $74,884,000.00
  • STHO $113,989,000.00
  • Revenue This Year
  • RCEL $22.92
  • STHO N/A
  • Revenue Next Year
  • RCEL $37.07
  • STHO N/A
  • P/E Ratio
  • RCEL N/A
  • STHO N/A
  • Revenue Growth
  • RCEL 38.32
  • STHO N/A
  • 52 Week Low
  • RCEL $3.60
  • STHO $6.06
  • 52 Week High
  • RCEL $14.16
  • STHO $13.50
  • Technical
  • Relative Strength Index (RSI)
  • RCEL 49.55
  • STHO 34.37
  • Support Level
  • RCEL $5.14
  • STHO $7.45
  • Resistance Level
  • RCEL $5.61
  • STHO $8.00
  • Average True Range (ATR)
  • RCEL 0.24
  • STHO 0.31
  • MACD
  • RCEL -0.03
  • STHO -0.08
  • Stochastic Oscillator
  • RCEL 41.94
  • STHO 25.00

About RCEL Avita Medical Inc.

Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in rollout across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.

About STHO Star Holdings Shares of Beneficial Interest

Star Holdings engages in non-ground lease-related businesses, including real estate finance, operating properties, and land and development. Its portfolio is comprised of its interests in Asbury and Magnolia Green residential development projects, a portfolio of commercial real estate properties, and loans that are being marketed for sale. The Company operates its business through one reportable and operating segment that focuses on realizing value for shareholders by generating cash flows through active asset management and sales of its existing loans, operating properties and land and development properties.

Share on Social Networks: